09 Sep 2015 --- Kaneka Pharma Europe, developer and patent holder of the liquorice root extract Glavonoid, has successfully secured extended use approval for the novel food ingredient from the European Commission. Glavonoid offers unique support in reducing visceral fat. Besides being used in food supplements and beverages based on milk, yoghurt, fruit and vegetables, as accredited by its Novel Food status since 2011, Glavonoid can now also be applied in foods intended for medical purposes and energy-restricted diets for weight reduction.
